Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Ratio Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
Novartis
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
Baylor College of Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
ViroMissile, Inc.
Emory University
Stanford University
Eisai Inc.
Poseida Therapeutics, Inc.
M.D. Anderson Cancer Center
Institut Bergonié
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
CEBIOTEX
EMD Serono
SEED Therapeutics, Inc.
M.D. Anderson Cancer Center
Seattle Children's Hospital
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
Angiex, Inc.
Fred Hutchinson Cancer Center
LTZ Therapeutics, Inc.
St. Jude Children's Research Hospital
Baylor College of Medicine
H. Lee Moffitt Cancer Center and Research Institute
MacroGenics